drugset / Trial / NCT00974571
Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess the ability of montelukast to improve the signs and symptoms of perennial allergic rhinitis compared to placebo. Cetirizine is included in the study as an active control.
Timeline
- Start
- 2001-11
- Primary completion
- 2002-05
- Completion
- 2002-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cetirizine | Other / unclassified | 10 mg | Oral |
| Subject | Montelukast | Other / unclassified | 10 mg | Oral |